Home Other Building Blocks 28957-04-2
28957-04-2,MFCD00221762
Catalog No.:AA002UWP

28957-04-2 | Oridonin

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
95%
in stock  
$32.00   $23.00
- +
100mg
95%
in stock  
$64.00   $45.00
- +
250mg
99%
in stock  
$93.00   $65.00
- +
1g
95%
in stock  
$286.00   $200.00
- +
5g
95%
in stock  
$1,239.00   $867.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002UWP
Chemical Name:
Oridonin
CAS Number:
28957-04-2
Molecular Formula:
C20H28O6
Molecular Weight:
364.4327
MDL Number:
MFCD00221762
SMILES:
C=C1[C@@H]2CC[C@H]3[C@@](C1=O)([C@@H]2O)[C@]1(O)OC[C@]23[C@@H](O)CCC([C@@H]2[C@@H]1O)(C)C
Properties
Computed Properties
 
Complexity:
717  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
4  
XLogP3:
0.1  

Downstream Synthesis Route
28957-04-2   
dihydrooridonin 

[1]JournalofMedicinalChemistry,2016,vol.59,p.5022-5034

[2]NatureCommunications,2018,vol.9

[3]JournaloftheChemicalSocietyC:Organic,1970,p.1674-1681

[1]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.2795-2800

[2]ACSMedicinalChemistryLetters,2014,vol.5,p.797-802

[3]RSCAdvances,2018,vol.8,p.29548-29554

[4]EuropeanJournalofMedicinalChemistry,2012,vol.52,p.242-250

[5]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.4191-4196

[6]Patent:CN106883267,2017,A.Locationinpatent:Paragraph0014

[7]JournalofMedicinalChemistry,2013,vol.56,p.5048-5058

[8]JournalofMedicinalChemistry,2013,vol.56,p.8814-8825

[9]Patent:WO2014/165841,2014,A1.Locationinpatent:Paragraph091

[10]Patent:US2014/364490,2014,A1.Locationinpatent:Paragraph0095-0098

[11]JournaloftheChemicalSocietyC:Organic,1970,p.1674-1681

[12]Molecules,2016,vol.21

[13]EuropeanJournalofMedicinalChemistry,2019,vol.178,p.446-457

[14]Patent:CN108299458,2018,A.Locationinpatent:Paragraph0197-0199

[15]EuropeanJournalofMedicinalChemistry,2020,vol.187

[16]Patent:CN110950883,2020,A.Locationinpatent:Paragraph0016;0024-0026

[1]Fitoterapia,2014,vol.99,p.300-306

[2]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.2795-2800

[3]JournalofMedicinalChemistry,2017,vol.60,p.1449-1468

[4]JournalofNaturalProducts,2017,vol.80,p.2391-2398

[5]Patent:WO2014/165841,2014,A1.Locationinpatent:Paragraph0106;0107

[6]TetrahedronLetters,2010,vol.51,p.1121-1123

[7]RSCAdvances,2018,vol.8,p.29548-29554

[8]EuropeanJournalofMedicinalChemistry,2012,vol.52,p.242-250

[9]ACSMedicinalChemistryLetters,2014,vol.5,p.797-802

[10]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.4191-4196

[11]EuropeanJournalofMedicinalChemistry,2013,vol.59,p.322-328

[12]EuropeanJournalofMedicinalChemistry,2019,vol.178,p.365-379

[13]EuropeanJournalofMedicinalChemistry,2019,vol.178,p.446-457

[14]EuropeanJournalofMedicinalChemistry,2020,vol.187

[1]EuropeanJournalofMedicinalChemistry,2012,vol.52,p.242-250

[2]Fitoterapia,2014,vol.99,p.300-306

[3]JournalofNaturalProducts,2017,vol.80,p.2391-2398

[4]EuropeanJournalofMedicinalChemistry,2012,vol.52,p.242-250

[5]InternationalJournalofMolecularSciences,2016,vol.17

[6]EuropeanJournalofMedicinalChemistry,2018,vol.146,p.588-598

28957-04-2   
(4aR,5S,6S,6aR,9S,11aS,11bR,14R)-5,6,14-trihydroxy-4,4-dimethyl-8-methylene-4,4a,5,6,9,10,11,11a-octahydro-3H-6,11b-(epoxymethano)-6a,9-methanocycloheptaanaphthalen-7(8H)-one 

[1]Patent:CN106749305,2017,A.Locationinpatent:Paragraph0099;0100;0101;0102;0103;0104

[2]Patent:WO2014/165841,2014,A1

[3]JournalofMedicinalChemistry,2017,vol.60,p.1449-1468

[4]JournalofNaturalProducts,2017,vol.80,p.2391-2398

Literature

Title: A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy.

Journal: Molecular pharmaceutics 20161107

Title: Inhibition of RNA transportation induces glioma cell apoptosis via downregulation of RanGAP1 expression.

Journal: Chemico-biological interactions 20150505

Title: Interaction of oridonin with human serum albumin by isothermal titration calorimetry and spectroscopic techniques.

Journal: Chemico-biological interactions 20150505

Title: The tyrphostin AG1478 augments oridonin-induced A431 cell apoptosis by blockage of JNK MAPK and enhancement of oxidative stress.

Journal: Free radical research 20121101

Title: Nitric oxide augments oridonin-induced efferocytosis by human histocytic lymphoma U937 cells via autophagy and the NF-κB-COX-2-IL-1β pathway.

Journal: Free radical research 20121001

Title: Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway.

Journal: International journal of oncology 20120901

Title: Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway.

Journal: Acta pharmacologica Sinica 20120801

Title: Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.

Journal: Molecules (Basel, Switzerland) 20120618

Title: The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.

Journal: European journal of medicinal chemistry 20120601

Title: [Longikaurin A induces apoptosis of multiple myeloma H929 cells].

Journal: Zhongguo shi yan xue ye xue za zhi 20120601

Title: [Anti-tumor effect of tanshinone II A, tetrandrine, honokiol, curcumin, oridonin and paeonol on leukemia cell lines].

Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20120501

Title: Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells.

Journal: International journal of molecular medicine 20120401

Title: In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.

Journal: International journal of biological macromolecules 20120401

Title: Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.

Journal: Science translational medicine 20120328

Title: Study on the autophagy of prostate cancer PC-3 cells induced by oridonin.

Journal: Anatomical record (Hoboken, N.J. : 2007) 20120301

Title: Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells.

Journal: Archives of biochemistry and biophysics 20120201

Title: Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro.

Journal: Journal of biomedical nanotechnology 20120201

Title: Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.

Journal: International journal of oncology 20120101

Title: Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1.

Journal: Acta pharmacologica Sinica 20120101

Title: RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.

Journal: International journal of nanomedicine 20120101

Title: Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line.

Journal: International journal of nanomedicine 20120101

Title: Optimisation of an ultrasound-assisted extraction followed by RP-HPLC separation for the simultaneous determination of oleanolic acid, ursolic acid and oridonin content in Rabdosia rubescens.

Journal: Phytochemical analysis : PCA 20120101

Title: Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells.

Journal: International journal of biological sciences 20120101

Title: Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin.

Journal: Biomacromolecules 20111212

Title: [Study on pharmacokinetics of oridonin in mice].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20111201

Title: Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.

Journal: Colloids and surfaces. B, Biointerfaces 20111015

Title: Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells.

Journal: Acta pharmacologica Sinica 20111001

Title: Isolation and purification of oridonin from the whole plant of Isodon rubescens by high-speed counter-current chromatography.

Journal: Molecules (Basel, Switzerland) 20110914

Title: Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-κB inhibitors is dependent on reactive oxygen species (ROS).

Journal: Journal of neuro-oncology 20110901

Title: Oridonin induced the apoptosis of PC-3 cells and its mechanism.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20110801

Title: Stimulation of suicidal erythrocyte death by oridonin.

Journal: Archives of biochemistry and biophysics 20110701

Title: Synthesis and revision of stereochemistry of rubescensin S.

Journal: Organic & biomolecular chemistry 20110621

Title: Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique.

Journal: International journal of pharmaceutics 20110615

Title: Proteomic and functional analyses reveal the potential involvement of endoplasmic reticulum stress and α-CP1 in the anticancer activities of oridonin in HepG2 cells.

Journal: Integrative cancer therapies 20110601

Title: Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting.

Journal: International journal of pharmaceutics 20110516

Title: Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension.

Journal: Drug delivery 20110501

Title: Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.

Journal: The international journal of biochemistry & cell biology 20110501

Title: Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals.

Journal: Cell biology and toxicology 20110401

Title: Downregulation of AP-1 gene expression is an initial event in the oridonin-mediated inhibition of colorectal cancer: studies in vitro and in vivo.

Journal: Journal of gastroenterology and hepatology 20110401

Title: Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20110115

Title: A novel analysis method for diterpenoids in rat plasma by liquid chromatography-electrospray ionization mass spectrometry.

Journal: Analytical biochemistry 20101201

Title: [Autophagy of prostate cancer PC-3 cells under the induction of oridonin].

Journal: Zhonghua yi xue za zhi 20101116

Title: Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.

Journal: Oncology reports 20100901

Title: Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.

Journal: Cancer letters 20100828

Title: Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells.

Journal: Journal of natural products 20100625

Title: Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.

Journal: Journal of microencapsulation 20100501

Title: Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells.

Journal: International journal of laboratory hematology 20100201

Title: Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB.

Journal: The Journal of pharmacology and experimental therapeutics 20100201

Title: Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line.

Journal: International journal of nanomedicine 20100101

Title: Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.

Journal: BMC cancer 20100101

Title: [Empirical study of oridonin-induced gastric cancer cells MKN45 apoptosis].

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 20091101

Title: Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells.

Journal: Archives of biochemistry and biophysics 20091001

Title: [Preparation and characterization of oridonin submicron emulsions].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20091001

Title: In vitro and in vivo antitumor activity of oridonin nanosuspension.

Journal: International journal of pharmaceutics 20090908

Title: NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway.

Journal: Archives of biochemistry and biophysics 20090901

Title: Effects and mechanism of oridonin on pulmonary hypertension induced by chronic hypoxia-hypercapnia in rats.

Journal: Chinese medical journal 20090620

Title: Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells.

Journal: Autophagy 20090401

Title: Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia.

Journal: International immunopharmacology 20090301

Title: Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells.

Journal: The FEBS journal 20090301

Title: Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: a protective mechanism against apoptosis.

Journal: Biochemical and biophysical research communications 20090109

Title: Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin.

Journal: International journal of pharmaceutics 20090105

Title: [Study on stability of oridonin solution].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20090101

Title: The effect of stealth liposomes on pharmacokinetics, tissue distribution and anti-tumor activity of oridonin.

Journal: PDA journal of pharmaceutical science and technology 20090101

Title: Oridonin confers protection against arsenic-induced toxicity through activation of the Nrf2-mediated defensive response.

Journal: Environmental health perspectives 20080901

Title: Caspase inhibition augmented oridonin-induced cell death in murine fibrosarcoma l929 by enhancing reactive oxygen species generation.

Journal: Journal of pharmacological sciences 20080901

Title: [Release kinetics of oridonin self-microemulsifying drug delivery system in vitro].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20080901

Title: Synthesis and biological evaluation of novel 1-O- and 14-O-derivatives of oridonin as potential anticancer drug candidates.

Journal: Bioorganic & medicinal chemistry letters 20080815

Title: Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways.

Journal: Journal of pharmacological sciences 20080801

Title: Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death.

Journal: Archives of biochemistry and biophysics 20080715

Title: Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.

Journal: Journal of drug targeting 20080701

Title: An HPLC method for determination of oridonin in rabbits using isopsoralen as an internal standard and its application to pharmacokinetic studies for oridonin-loaded nanoparticles.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080615

Title: Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin.

Journal: Drug development and industrial pharmacy 20080601

Title: Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.

Journal: International journal of pharmaceutics 20080501

Title: Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.

Journal: International journal of pharmaceutics 20080501

Title: Oridonin promotes CD4+/CD25+ Treg differentiation, modulates Th1/Th2 balance and induces HO-1 in rat splenic lymphocytes.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080401

Title: Down-regulation of androgen-receptor and PSA by phytochemicals.

Journal: International journal of oncology 20080201

Title: [Inhibitory effect of Oridonin injection on heterotransplanted gastric adenocarcinoma in nude mice and its mechanism].

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080201

Title: Oridonin induces human epidermoid carcinoma A431 cell apoptosis through tyrosine kinase and mitochondrial pathway.

Journal: Journal of Asian natural products research 20080101

Title: Oridonin induces human melanoma A375-S2 cell death partially through inhibiting insulin-like growth factor 1 receptor signaling.

Journal: Journal of Asian natural products research 20080101

Title: Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation.

Journal: Journal of pharmacological sciences 20071201

Title: Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement.

Journal: Drug development and industrial pharmacy 20071201

Title: Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line.

Journal: Acta pharmacologica Sinica 20071101

Title: Authentication and chemical study of isodonis herba and isodonis extracts.

Journal: Chemical & pharmaceutical bulletin 20071101

Title: [Determination of oridonin and rosemarinic acid in Rabdosia rubescens by HPLC].

Journal: Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20071101

Title: [Effects of Oridonin on proliferation in human nasopharyngeal carcinoma line CNE 2 in vitro].

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery 20071001

Title: Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells.

Journal: Journal of pharmacological sciences 20070901

Title: Studies on the cell-immunosuppressive mechanism of Oridonin from Isodon serra.

Journal: International immunopharmacology 20070701

Title: P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.

Journal: Acta pharmacologica Sinica 20070701

Title: Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice.

Journal: Die Pharmazie 20070601

Title: Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells.

Journal: Biological & pharmaceutical bulletin 20070501

Title: Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.

Journal: Blood 20070415

Title: Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo.

Journal: Cell research 20070401

Title: Effective two-dimensional counter-current chromatographic method for simultaneous isolation and purification of oridonin and ponicidin from the crude extract of Rabdosia rubescens.

Journal: Journal of chromatography. A 20070330

Title: Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells.

Journal: Cancer biology & therapy 20070201

Title: Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells.

Journal: Biological & pharmaceutical bulletin 20070201

Title: Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo.

Journal: International journal of biological macromolecules 20070130

Title: Determination of oridonin in rat plasma by reverse-phase high-performance liquid chromatography.

Journal: Journal of pharmaceutical and biomedical analysis 20070117

Title: Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway.

Journal: Journal of pharmacological sciences 20070101

Title: [Mechanism of downregulation of apoptosis by autophagy induced by oridonin in HeLa cells].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20070101

Title: Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.

Journal: Acta pharmacologica Sinica 20061201

Title: Fibroblast growth factor-2 suppresses oridonin-induced L929 apoptosis through extracellular signal-regulated kinase-dependent and phosphatidylinositol 3-kinase-independent pathway.

Journal: Journal of pharmacological sciences 20061101

Title: [Change of Bcl-2 expression and telomerase during apoptosis induced by oridonin on human hepatocelluar carcinoma cells].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20061101

Title: Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells.

Journal: Biological & pharmaceutical bulletin 20060901

Title: A rapid HPLC/ESI-MS method for the quantitative determination of oridonin in rat plasma.

Journal: Die Pharmazie 20060901

Title: Augmentation of oridonin-induced apoptosis observed with reduced autophagy.

Journal: Journal of pharmacological sciences 20060701

Title: Celastrol, a triterpene extracted from the Chinese 'Thunder of God Vine,' is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.

Journal: Cancer research 20060501

Title: Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells.

Journal: International immunopharmacology 20060201

Title: Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action.

Journal: American journal of hematology 20060201

Title: Isolation and purification of oridonin from Rabdosia rubescens using upright counter-current chromatography.

Journal: Journal of separation science 20060201

Title: The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells.

Journal: Journal of ethnopharmacology 20060116

Title: A comparison of the signal pathways between the TNF alpha- and oridonin-induced murine L929 fibrosarcoma cell death.

Journal: Acta medica Okayama 20051201

Title: [Oridonin induced U937 cell apoptosis through ERK pathway].

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20051201

Title: Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.

Journal: Biochemical and biophysical research communications 20051111

Title: Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis.

Journal: Biological & pharmaceutical bulletin 20051101

Title: Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells.

Journal: Journal of pharmacological sciences 20050801

Title: [The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20050601

Title: Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.

Journal: Molecular cancer therapeutics 20050401

Title: Apoptotic effect of oridonin on NB4 cells and its mechanism.

Journal: Leukemia & lymphoma 20050401

Title: The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.

Journal: International journal of oncology 20050301

Title: Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells.

Journal: Biological & pharmaceutical bulletin 20050301

Title: Oridonin-induced apoptosis in leukemia K562 cells and its mechanism.

Journal: Neoplasma 20050101

Title: Antiproliferation effects of oridonin on HL-60 cells.

Journal: Annals of hematology 20041101

Title: [Regulation of telomerase activity and cell cycle of K562 cells by oridonin].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20041101

Title: Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929.

Journal: Biological & pharmaceutical bulletin 20041001

Title: Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation.

Journal: Journal of pharmacological sciences 20041001

Title: Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome.

Journal: Journal of Asian natural products research 20040601

Title: Anti-proliferation effect of oridonin on HL-60 cells and its mechanism.

Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20040601

Title: Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway.

Journal: Acta pharmacologica Sinica 20040501

Title: Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.

Journal: Journal of natural products 20040101

Title: Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action.

Journal: The Journal of international medical research 20040101

Title: Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.

Journal: International journal of oncology 20031001

Title: Taibaijaponicains C and D: two new diterpenoids from Isodon japonica.

Journal: Planta medica 20020501

Title: Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori.

Journal: Zentralblatt fur Bakteriologie : international journal of medical microbiology 19970601

Title: Song M, et al. Targeting AKT with oridonin inhibits growth of esophageal squamous cell carcinoma in vitro and patient derived xenografts in vivo. Mol Cancer Ther. 2018 Apr 25. pii: molcanther.0823.2017.

Title: Sun B, et al. Oridonin inhibits aberrant AKT activation in breast cancer. Oncotarget. 2018 Feb 1;9(35):23878-23889.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:28957-04-2 Molecular Formula|28957-04-2 MDL|28957-04-2 SMILES|28957-04-2 Oridonin